ROME, Nov 20 (Reuters) - Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp , a government document sent to parliament showed.
Golden powers legislation requires Italian government approval for any decision which results in changes in the ownership, control or availability of strategic assets in the country.
Italy's cabinet authorised the transaction on Nov. 12 with some unspecified conditions, according to the document.
Announced in September, the deal is worth some 150 million euros ($158.48 million).
($1 = 0.9465 euros)
(Reporting by Giuseppe Fonte, Editing by Louise Heavens)
((giuseppe.fonte@thomsonreuters.com; +390680307711;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。